Skip to Content

Trivaris Approval History

  • FDA approved: Yes (First approved June 16th, 2008)
  • Brand name: Trivaris
  • Generic name: triamcinolone acetonide
  • Dosage form: Intravitreal Injection
  • Company: Allergan, Inc.
  • Treatment for: Ocular Inflammatory Conditions

Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Development History and FDA Approval Process for Trivaris

DateArticle
Jun 17, 2008Approval Allergan Receives U.S. Food and Drug Administration Approval for Trivaris (triamcinolone acetonide injectable suspension) 80 mg/mL

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide